Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. (Q36041017)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. |
scientific article |
Statements
1 reference
Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. (English)
1 reference
Ritsuko Komaki
1 reference
Rebecca Paulus
1 reference
David S Ettinger
1 reference
Gregory M M Videtic
1 reference
Jeffrey D Bradley
1 reference
Bonnie S Glisson
1 reference
Corey J Langer
1 reference
William T Sause
1 reference
Walter J Curran
1 reference
Hak Choy
1 reference
5 May 2012
1 reference
1 reference
e531-6
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference